Palatin to Report Second Quarter, Fiscal Year 2022 Results; Teleconference and Webcast to be held on February 15, 2022

Rhea-AI Summary

Palatin Technologies, Inc. (PTN) is set to announce its Q2 fiscal year 2022 operating results on February 15, 2022, prior to the market opening. Following the release, a conference call will take place at 11:00 a.m. ET, featuring a review of operating results and updates on ongoing programs. The event will be accessible via live audio webcast. Investors can access replay details from Palatin's website. Palatin focuses on developing innovative therapies targeting unmet medical needs within biopharmaceuticals.

Positive

• Scheduled announcement of Q2 fiscal year 2022 operating results.
• Conference call to provide operational updates and program developments.
• Company's focus on first-in-class medicines with significant commercial potential.

Negative

• None.

CRANBURY, N.J., Feb. 10, 2022 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) will announce its second quarter, fiscal year 2022 operating results on Tuesday, February 15, 2022, before the open of the U.S. financial markets.

Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on February 15, 2022, at 11:00 a.m. ET. The conference call will include a review of the company's operating results and an update on programs under development.

Schedule for the Operating Results Press Release, Conference Call / Audio Webcast

Q2 Fiscal Year 2022 Results Press Release	2/15/2022 at 7:30 a.m. ET
Q2 Fiscal Year 2022 Conference Call-Live	2/15/2022 at 11:00 a.m. ET
US/Canada Dial-In Number:	1-800-289-0720
International Dial-In Number:	1-856-344-9142
Conference ID:	8966903
Q2 Fiscal Year 2022 Conference Call-Replay	2/15/2022-2/22/2022
US/Canada Dial-In Number:	1-888-203-1112
International Dial-In Number:	1-719-457-0820
Replay Passcode:	8966903
Audio Webcast Live and Replay Access	http://www.palatin.com

The audio webcast and replay can be accessed by logging on to the "Investors-Webcasts" section of Palatin's website at http://www.palatin.com.

About Palatin

Palatin is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems, with targeted, receptor-specific product candidates for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin's website at www.palatin.com and follow Palatin on Twitter at @PalatinTech.

View original content to download multimedia:https://www.prnewswire.com/news-releases/palatin-to-report-second-quarter-fiscal-year-2022-results-teleconference-and-webcast-to-be-held-on-february-15-2022-301479382.html

SOURCE Palatin Technologies, Inc.

FAQ

When will Palatin Technologies announce its Q2 fiscal year 2022 results?

Palatin Technologies will announce its Q2 fiscal year 2022 results on February 15, 2022, before the market opens.

What time is the conference call for Palatin's Q2 fiscal year 2022 results?

The conference call for Palatin's Q2 fiscal year 2022 results is scheduled for 11:00 a.m. ET on February 15, 2022.

How can I access the audio webcast for Palatin's conference call?

The audio webcast for Palatin's conference call can be accessed through the 'Investors-Webcasts' section of their website.

What is the focus of Palatin Technologies as a biopharmaceutical company?

Palatin Technologies focuses on developing first-in-class medicines targeting unmet medical needs and commercial opportunities.